181 related articles for article (PubMed ID: 14519103)
1. Transcriptional and translational control of ornithine decarboxylase during Ras transformation.
Shantz LM
Biochem J; 2004 Jan; 377(Pt 1):257-64. PubMed ID: 14519103
[TBL] [Abstract][Full Text] [Related]
2. Ras transformation of RIE-1 cells activates cap-independent translation of ornithine decarboxylase: regulation by the Raf/MEK/ERK and phosphatidylinositol 3-kinase pathways.
Origanti S; Shantz LM
Cancer Res; 2007 May; 67(10):4834-42. PubMed ID: 17510413
[TBL] [Abstract][Full Text] [Related]
3. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
Shantz LM; Pegg AE
Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells.
Hayes CS; DeFeo K; Lan L; Paul B; Sell C; Gilmour SK
Oncogene; 2006 Mar; 25(10):1543-53. PubMed ID: 16278677
[TBL] [Abstract][Full Text] [Related]
5. Induction of ornithine decarboxylase activity is a necessary step for mitogen-activated protein kinase kinase-induced skin tumorigenesis.
Feith DJ; Bol DK; Carboni JM; Lynch MJ; Sass-Kuhn S; Shoop PL; Shantz LM
Cancer Res; 2005 Jan; 65(2):572-8. PubMed ID: 15695401
[TBL] [Abstract][Full Text] [Related]
6. Cells transformed by ODC, c-Ha-ras and v-src exhibit MAP kinase/Erk-independent constitutive phosphorylation of Sos, Raf and c-Jun activation domain, and reduced PDGF receptor expression.
Paasinen-Sohns A; Hölttä E
Oncogene; 1997 Oct; 15(16):1953-66. PubMed ID: 9365242
[TBL] [Abstract][Full Text] [Related]
7. Reversible regulation of the transformed phenotype of ornithine decarboxylase- and ras-overexpressing cells by dominant-negative mutants of c-Jun.
Kielosto M; Nummela P; Katainen R; Leaner V; Birrer MJ; Hölttä E
Cancer Res; 2004 Jun; 64(11):3772-9. PubMed ID: 15172983
[TBL] [Abstract][Full Text] [Related]
8. Gastrin induces phosphorylation of eIF4E binding protein 1 and translation initiation of ornithine decarboxylase mRNA.
Pyronnet S; Gingras AC; Bouisson M; Kowalski-Chauvel A; Seva C; Vaysse N; Sonenberg N; Pradayrol L
Oncogene; 1998 Apr; 16(17):2219-27. PubMed ID: 9619831
[TBL] [Abstract][Full Text] [Related]
9. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
Voskas D; Mader R; Lee J; Hurta RA
Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
[TBL] [Abstract][Full Text] [Related]
10. Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E.
Shantz LM; Hu RH; Pegg AE
Cancer Res; 1996 Jul; 56(14):3265-9. PubMed ID: 8764119
[TBL] [Abstract][Full Text] [Related]
11. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
Hurta RA; Lee J; Voskas D
J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
[TBL] [Abstract][Full Text] [Related]
12. Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H-ras transformed cell lines.
Hurta RA; Wright JA
J Cell Physiol; 1994 Nov; 161(2):383-91. PubMed ID: 7525612
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor mediated altered expression and regulation of ornithine decarboxylase in H-ras-transformed cell lines.
Voskas D; Kim M; Hurta RA
Cell Signal; 2001 Jun; 13(6):401-9. PubMed ID: 11384838
[TBL] [Abstract][Full Text] [Related]
14. Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation.
Shantz LM; Coleman CS; Pegg AE
Cancer Res; 1996 Nov; 56(22):5136-40. PubMed ID: 8912847
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway.
Pervin S; Singh R; Hernandez E; Wu G; Chaudhuri G
Cancer Res; 2007 Jan; 67(1):289-99. PubMed ID: 17210710
[TBL] [Abstract][Full Text] [Related]
16. Translation of ODC mRNA and polyamine transport are suppressed in ras-transformed CREF cells by depleting translation initiation factor 4E.
Graff JR; De Benedetti A; Olson JW; Tamez P; Casero RA; Zimmer SG
Biochem Biophys Res Commun; 1997 Nov; 240(1):15-20. PubMed ID: 9367873
[TBL] [Abstract][Full Text] [Related]
17. Ornithine decarboxylase mRNA is stabilized in an mTORC1-dependent manner in Ras-transformed cells.
Origanti S; Nowotarski SL; Carr TD; Sass-Kuhn S; Xiao L; Wang JY; Shantz LM
Biochem J; 2012 Feb; 442(1):199-207. PubMed ID: 22070140
[TBL] [Abstract][Full Text] [Related]
18. Increased translation efficiency and antizyme-dependent stabilization of ornithine decarboxylase in amino acid-supplemented human colon adenocarcinoma cells, Caco-2.
Chabanon H; Persson L; Wallace HM; Ferrara M; Brachet P
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):401-8. PubMed ID: 10816435
[TBL] [Abstract][Full Text] [Related]
19. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
[TBL] [Abstract][Full Text] [Related]
20. Ornithine decarboxylase- and ras-induced cell transformations: reversal by protein tyrosine kinase inhibitors and role of pp130CAS.
Auvinen M; Paasinen-Sohns A; Hirai H; Andersson LC; Hölttä E
Mol Cell Biol; 1995 Dec; 15(12):6513-25. PubMed ID: 8524216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
